Clinical trial
Pilot Prospective Single-center Non-comparative Study: Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
NCT07141732 is registered in ClinicalTrials.gov with Joint Stock Company European Medical Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Prospective Single-center Non-comparative Study: Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
- Lead sponsor
- Joint Stock Company European Medical Centre
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- September 1, 2025
- Completion date
- March 1, 2029
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.